PRECIPIO, INC. Debt Conversion, Converted Instrument, Amount
PRECIPIO, INC. (PRPO) reported Debt Conversion, Converted Instrument, Amount of $2.18 million for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-30.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2022-03-30
- PRECIPIO, INC. debt conversion, converted instrument, amount for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
- PRECIPIO, INC. debt conversion, converted instrument, amount for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- PRECIPIO, INC. debt conversion, converted instrument, amount for the quarter ending 2020-06-30 was $1.82M, a 57.99% decline year-over-year.
- PRECIPIO, INC. debt conversion, converted instrument, amount for the quarter ending 2020-03-31 was $353.00K, a 87.96% decline year-over-year.
- PRECIPIO, INC. debt conversion, converted instrument, amount for fiscal 2020 was $2.18M, a 71.19% decline from fiscal 2019.
- PRECIPIO, INC. debt conversion, converted instrument, amount for fiscal 2019 was $7.55M, a 220.59% increase from fiscal 2018.
- PRECIPIO, INC. debt conversion, converted instrument, amount for fiscal 2018 was $2.36M.
- PRECIPIO, INC. debt conversion, converted instrument, amount for fiscal 2016 was $807.00K, a 20.26% decline from fiscal 2015.
| Period end | Debt Conversion, Converted Instrument, Amount | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 3 month as first filed | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 6 month as first filed | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month | Debt Conversion, Converted Instrument, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $0.00 derived: sum of 2 quarters · filed 2022-03-30 | $1.82M derived: sum of 3 quarters · filed 2022-03-30 | $2.18M 10-K · filed 2022-03-30 | ||||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $1.82M derived: sum of 2 quarters · filed 2021-11-12 | $2.18M 10-Q · filed 2021-11-12 | $2.34M derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | $1.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $2.18M 10-Q · filed 2021-08-12 | $1.94M 10-Q · filed 2020-08-13 | $2.34M derived: sum of 3 quarters · filed 2021-08-12 | $2.46M derived: sum of 4 quarters · filed 2021-08-12 | |||
| 2020-03-31 | $353.00K 10-Q · filed 2021-05-14 | $325.00K 10-Q · filed 2020-05-14 | $516.00K derived: sum of 2 quarters · filed 2021-05-14 | $634.00K derived: sum of 3 quarters · filed 2021-05-14 | $4.97M derived: sum of 4 quarters · filed 2021-05-14 | |||
| 2019-12-31 | $163.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $281.00K derived: sum of 2 quarters · filed 2021-03-29 | $4.62M derived: sum of 3 quarters · filed 2021-03-29 | $7.55M 10-K · filed 2021-03-29 | ||||
| 2019-09-30 | $118.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $4.46M derived: sum of 2 quarters · filed 2020-11-13 | $7.39M 10-Q · filed 2020-11-13 | $7.59M derived: sum of 4 quarters · filed 2020-11-13 | ||||
| 2019-06-30 | $4.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $7.27M 10-Q · filed 2020-08-13 | $7.47M derived: sum of 3 quarters · filed 2020-08-13 | $9.42M derived: sum of 4 quarters · filed 2020-08-13 | ||||
| 2019-03-31 | $2.93M 10-Q · filed 2020-05-14 | $3.13M derived: sum of 2 quarters · filed 2020-05-14 | $5.08M derived: sum of 3 quarters · filed 2020-05-14 | $3.34M derived: sum of 4 quarters · filed 2020-05-14 | ||||
| 2019-02-12 | $1.90M 10-Q · filed 2019-11-13 | |||||||
| 2018-12-31 | $200.00K 10-Q · filed 2019-05-16 | $2.14M derived: sum of 2 quarters · filed 2019-05-16 | $411.00K derived: sum of 3 quarters · filed 2019-05-16 | $2.36M 10-K · filed 2020-03-27 | $3.19M 10-K · filed 2019-04-16 | |||
| 2018-09-30 | $1.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-19 | $211.00K derived: sum of 2 quarters · filed 2018-11-19 | $2.11M 10-Q · filed 2018-11-19 | |||||
| 2018-06-30 | -$1.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-16 | $164.00K 10-Q · filed 2018-08-16 | ||||||
| 2018-03-31 | $1.90M 10-Q · filed 2018-05-21 | |||||||
| 2018-02-12 | $1.90M 10-K · filed 2020-03-27 | |||||||
| 2017-03-31 | $499.00K 10-Q · filed 2017-05-18 | |||||||
| 2016-12-31 | $807.00K 10-K · filed 2017-04-13 | |||||||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-18 | $0.00 derived: sum of 2 quarters · filed 2017-05-18 | $0.00 derived: sum of 3 quarters · filed 2017-05-18 | |||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-13 | $0.00 derived: sum of 2 quarters · filed 2017-04-13 | $1.01M 10-K · filed 2017-04-13 | |||||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | $1.01M 10-Q · filed 2015-11-16 | ||||||
| 2015-06-30 | $1.01M 10-Q · filed 2015-08-14 | |||||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-14 | $0.00 derived: sum of 2 quarters · filed 2016-04-14 | $0.00 10-K · filed 2016-04-14 | |||||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | $0.00 10-Q · filed 2015-11-16 | ||||||
| 2014-06-30 | $0.00 10-Q · filed 2015-08-14 | |||||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-15 | $0.00 derived: sum of 2 quarters · filed 2015-04-15 | $0.00 derived: sum of 3 quarters · filed 2015-04-15 | $0.00 10-K · filed 2015-04-15 | ||||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $0.00 derived: sum of 2 quarters · filed 2013-11-14 | $0.00 10-Q · filed 2013-11-14 | $0.00 derived: sum of 4 quarters · filed 2015-04-15 | ||||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $0.00 10-Q · filed 2013-08-08 | $0.00 derived: sum of 3 quarters · filed 2015-04-15 | $0.00 derived: sum of 4 quarters · filed 2015-04-15 | ||||
| 2013-03-31 | $0.00 10-Q · filed 2013-05-09 | $0.00 derived: sum of 2 quarters · filed 2015-04-15 | $0.00 derived: sum of 3 quarters · filed 2015-04-15 | $0.00 derived: sum of 4 quarters · filed 2015-04-15 | ||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-15 | $0.00 derived: sum of 2 quarters · filed 2015-04-15 | $0.00 derived: sum of 3 quarters · filed 2015-04-15 | $3.00M 10-K · filed 2015-04-15 | ||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $0.00 derived: sum of 2 quarters · filed 2013-11-14 | $3.00M 10-Q · filed 2013-11-14 | $3.00M derived: sum of 4 quarters · filed 2014-03-27 | ||||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $3.00M 10-Q · filed 2013-08-08 | $3.00M derived: sum of 3 quarters · filed 2014-03-27 | $3.00M derived: sum of 4 quarters · filed 2014-03-27 | ||||
| 2012-03-31 | $3.00M 10-Q · filed 2013-05-09 | $3.00M derived: sum of 2 quarters · filed 2014-03-27 | $3.00M derived: sum of 3 quarters · filed 2014-03-27 | $3.00M derived: sum of 4 quarters · filed 2014-03-27 | ||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $0.00 derived: sum of 2 quarters · filed 2014-03-27 | $0.00 derived: sum of 3 quarters · filed 2014-03-27 | $0.00 10-K · filed 2014-03-27 | ||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $0.00 derived: sum of 2 quarters · filed 2012-11-08 | $0.00 10-Q · filed 2012-11-08 | |||||
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | $0.00 10-Q · filed 2012-08-02 | ||||||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-09 | |||||||
| 2010-12-31 | $0.00 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |